| They've also done two other great episodes on patents: 412 - http://www.npr.org/blogs/money/2012/10/23/163480928/episode-... 551 - http://www.npr.org/blogs/money/2014/07/09/329895088/episode-... Side topic, but I really wish Planet Money would look into medical re-patenting. Growing up I needed albuterol inhalers occasionally and I remember them costing less than $10, but recently my kid needed one and it was $60 with copay (over $100 without insurance). That's when I found this article: http://www.nytimes.com/2013/10/13/us/the-soaring-cost-of-a-s... TL;DR - Inhalers use CFC's (ozone hole making), but scientists and environmentalists recommended an exception for them when banning CFC's because the amounts were so tiny and the medical benefits so huge. The pharmaceutical industry decided to lobby against the exception so they could reformulate the inhaler and introduce a new patent - and make billions on a 30+ year old drug. |
Its unreasonable to expect a publicly traded company to do anything other than chase profits the best way they can.